Carlton Hofferkamp & Jenks Wealth Management’s Gilead Sciences GILD Stock Holding History

Carlton Hofferkamp & Jenks Wealth Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$546K	Sell	4,190 -25	-0.6%	-$3.29K	0.18%	88
2026 Q1	$538K	Sell	4,215 -1,095	-21%	-$153K	0.18%	88
2025 Q4	$652K	Sell	5,310 -35	-0.7%	-$4.25K	0.22%	81
2025 Q3	$644K	Sell	5,345 -250	-4%	-$28.4K	0.22%	81
2025 Q2	$642K	Sell	5,595 -255	-4%	-$27.1K	0.23%	81
2025 Q1	$614K	Hold	5,850	–	–	0.25%	80
2024 Q4	$583K	Sell	5,850 -700	-11%	-$63K	0.22%	85
2024 Q3	$588K	Sell	6,550 -200	-3%	-$15.3K	0.22%	85
2024 Q2	$527K	Hold	6,750	–	–	0.21%	89
2024 Q1	$441K	Sell	6,750 -30	-0.4%	-$2.31K	0.19%	93
2023 Q4	$539K	Sell	6,780 -100	-1%	-$7.78K	0.23%	82
2023 Q3	$539K	Hold	6,880	–	–	0.25%	81
2023 Q2	$541K	Sell	6,880 -210	-3%	-$16.7K	0.24%	85
2023 Q1	$554K	Sell	7,090 -500	-7%	-$41.4K	0.25%	85
2022 Q4	$636K	Sell	7,590 -600	-7%	-$47.5K	0.28%	84
2022 Q3	$555K	Hold	8,190	–	–	0.26%	87
2022 Q2	$515K	Hold	8,190	–	–	0.24%	91
2022 Q1	$510K	Buy	8,190 +250	+3%	+$16K	0.21%	93
2021 Q4	$547K	Buy	7,940 +125	+2%	+$8.61K	0.23%	91
2021 Q3	$516K	Buy	7,815 +135	+2%	+$9.48K	0.21%	95
2021 Q2	$527K	Buy	7,680 +300	+4%	+$20K	0.23%	90
2021 Q1	$477K	Buy	7,380 +1,055	+17%	+$68K	0.21%	88
2020 Q4	$424K	Sell	6,325 -3,550	-36%	-$214K	0.21%	88
2020 Q3	$593K	Buy	9,875 +375	+4%	+$26K	0.31%	73
2020 Q2	$694K	Buy	9,500 +3,450	+57%	+$264K	0.4%	65
2020 Q1	$503K	Sell	6,050 -3,650	-38%	-$252K	0.31%	73
2019 Q4	$619K	Buy	9,700 +1,650	+20%	+$107K	0.35%	66
2019 Q3	$509K	Buy	8,050 +300	+4%	+$19.6K	0.31%	66
2019 Q2	$519K	Buy	7,750 +300	+4%	+$19.7K	0.31%	69
2019 Q1	$484K	Hold	7,450	–	–	0.3%	67
2018 Q4	$465K	Hold	7,450	–	–	0.33%	63
2018 Q3	$575K	Sell	7,450 -6,000	-45%	-$453K	0.35%	63
2018 Q2	$944K	Buy	+13,450	New	+$950K	0.61%	44
2017 Q3	–	Sell	-5,254	Closed	-$371K	–	89
2017 Q2	$371K	Sell	5,254 -4,700	-47%	-$313K	0.25%	72
2017 Q1	$676K	Sell	9,954 -19,162	-66%	-$1.35M	0.47%	54
2016 Q4	$2.08M	Sell	29,116 -54	-0.2%	-$4.01K	1.52%	15
2016 Q3	$2.31M	Buy	29,170 +100	+0.3%	+$8.12K	1.8%	13
2016 Q2	$2.42M	Buy	29,070 +1,000	+4%	+$88.7K	1.91%	12
2016 Q1	$2.58M	Buy	28,070 +22,603	+413%	+$2.04M	2.1%	10
2015 Q4	$535K	Hold	5,467	–	–	0.46%	55
2015 Q3	$536K	Buy	5,467 +158	+3%	+$17.5K	0.52%	48
2015 Q2	$615K	Sell	5,309 -425	-7%	-$46.4K	0.57%	46
2015 Q1	$562K	Hold	5,734	–	–	0.56%	45
2014 Q4	$540K	Buy	5,734 +425	+8%	+$44K	0.48%	44
2014 Q3	$561K	Buy	+5,309	New	+$520K	0.64%	43

Other funds holding GILD

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

ECSS

Eurizon Capital SGR SpA Milan $37.3B AUM

CIM

Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return

Carlton Hofferkamp & Jenks Wealth Management's GILD Position: Q2 2026 in Review

Carlton Hofferkamp & Jenks Wealth Management reduced its Gilead Sciences (GILD) stake by 0.59% in Q2 2026, selling an estimated $3.29K and leaving 4,190 shares worth $546K. The position accounts for 0.18% of the portfolio, ranked #88.

Carlton Hofferkamp & Jenks Wealth Management first reported a position in GILD in Q3 2014 and has held it in 45 quarters since. The position peaked at $2.58M in Q1 2016. 927 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

Carlton Hofferkamp & Jenks Wealth Management held 4,190 shares of Gilead Sciences worth $546K as of Q2 2026.
Carlton Hofferkamp & Jenks Wealth Management sold 25 Gilead Sciences shares in Q2 2026, an estimated $3.29K.
Gilead Sciences made up 0.18% of Carlton Hofferkamp & Jenks Wealth Management's portfolio in Q2 2026, its #88 holding.
Carlton Hofferkamp & Jenks Wealth Management first reported a position in Gilead Sciences in Q3 2014 and has held it in 45 quarters since.
Carlton Hofferkamp & Jenks Wealth Management's Gilead Sciences position peaked at $2.58M in Q1 2016.
927 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Carlton Hofferkamp & Jenks Wealth Management's 13F filing for Q2 2026, filed 23 Jul 2026.